Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Disintegration/dissolution profiles of copies of Fosamax (alendronate).

Epstein S, Cryer B, Ragi S, Zanchetta JR, Walliser J, Chow J, Johnson MA, Leyes AE.

Curr Med Res Opin. 2003;19(8):781-9. Erratum in: Curr Med Res Opin. 2004 Apr;20(4):575.

PMID:
14687450
2.

Comment on Disintegration/dissolution profiles of copies of Fosamax (alendronate).

Bolaños Díaz R.

Curr Med Res Opin. 2004 Jul;20(7):1035-6; author reply 1036-7. No abstract available.

PMID:
15265248
3.

In vitro disintegration studies of weekly generic alendronate sodium tablets (70 mg) available in the US.

Dansereau RJ, Crail DJ, Perkins AC.

Curr Med Res Opin. 2009 Feb;25(2):449-52. doi: 10.1185/03007990802648903 .

PMID:
19192989
4.

In vitro disintegration and dissolution studies of once-weekly copies of alendronate sodium tablets (70 mg) and in vivo implications.

Dansereau RJ, Crail DJ, Perkins AC.

Curr Med Res Opin. 2008 Apr;24(4):1137-45. doi: 10.1185/030079908X280725 .

PMID:
18334082
5.

Comparative in vitro study of oesophageal adhesiveness of different commercial formulations containing alendronate.

Shakweh M, Bravo-Osuna I, Ponchel G.

Eur J Pharm Sci. 2007 Aug;31(5):262-70.

PMID:
17576054
6.
7.
8.

Comparison of dissolution profiles for albendazole tablets using USP apparatus 2 and 4.

Hurtado y de la Peña M, Vargas Alvarado Y, Domínguez-Ramírez AM, Cortés Arroyo AR.

Drug Dev Ind Pharm. 2003 Aug;29(7):777-84.

PMID:
12906335
9.

In vitro and in vivo equivalence studies of alendronate monosodium tablets.

Roldán EJ, Quattrocchi O, Zanetti D, Piccinni E, Tessler J, Caballero LE, Lloret AP.

Arzneimittelforschung. 2005;55(2):93-101.

PMID:
15787276
10.

Comparison of simvastatin tablets from the US and international markets obtained via the Internet.

Veronin MA, Nguyen NT.

Ann Pharmacother. 2008 May;42(5):613-20. doi: 10.1345/aph.1K560.

PMID:
18413690
11.
12.

In vitro disintegration studies of weekly generic and branded risedronate sodium formulations available in Canada.

Walker AD, Adachi JD.

Curr Med Res Opin. 2011 Sep;27(9):1749-54. doi: 10.1185/03007995.2011.604309.

PMID:
21781014
13.

[Comparison in dissolution behavior of ethical and over-the counter scopolamine butylbromide].

Suzuki I, Miyazaki Y, Uchino T, Kagawa Y.

Yakugaku Zasshi. 2011;131(11):1645-51. Japanese.

14.

Comparative dissolution performance of internationally available piroxicam products.

Barone JA, Lordi NG, Byerly WG, Colaizzi JL.

Drug Intell Clin Pharm. 1988 Jan;22(1):35-40.

PMID:
3349918
15.

[Esophagitis associated with use of alendronate in 5 postmenopausic patients].

Luciani J, Pigatto V, Naves A, Fay M, Silvestre Begnis M, Piola JC, Prada DB, Pedrana R.

Acta Gastroenterol Latinoam. 2001 May;31(2):59-63. Spanish.

PMID:
11471319
16.

Quality and stability of ramipril generics/copies versus reference ramipril (Tritace): a 3-month stability comparative study.

Angeli DG, Trezza C.

Clin Drug Investig. 2009;29(10):667-76. doi: 10.2165/11315270-000000000-00000.

PMID:
19715383
17.

Esophageal transit and in vivo disintegration of branded risedronate sodium tablets and two generic formulations of alendronic acid tablets: a single-center, single-blind, six-period crossover study in healthy female subjects.

Perkins AC, Blackshaw PE, Hay PD, Lawes SC, Atherton CT, Dansereau RJ, Wagner LK, Schnell DJ, Spiller RC.

Clin Ther. 2008 May;30(5):834-44. doi: 10.1016/j.clinthera.2008.04.018.

PMID:
18555931
18.
19.

In vitro bioequivalence study of nine brands of artesunate tablets marketed in Nigeria.

Esimone CO, Okoye FB, Onah BU, Nworu CS, Omeje EO.

J Vector Borne Dis. 2008 Mar;45(1):60-5.

20.

Comparative studies on the in vitro drug dissolution profiles for hydroxyzine hydrochloride tablets.

Loucas SP, Maager P, Mehl B.

Ann Pharmacother. 1993 Jan;27(1):13-8.

PMID:
8431611
Items per page

Supplemental Content

Support Center